Publications in collaboration with researchers from Universitat Politècnica de Catalunya (35)

2022

  1. Effects of Mixing Energy Drinks With Alcohol on Driving-Related Skills

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 1, pp. 13-25

  2. Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)

    Genetics in Medicine, Vol. 24, Núm. 10, pp. 2004-2013

2021

  1. Daidzein modulates cocaine-reinforcing effects and cue-induced cocaine reinstatement in CD-1 male mice

    Psychopharmacology, Vol. 238, Núm. 7, pp. 1923-1936

2020

  1. A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

    Clinical Nutrition, Vol. 39, Núm. 2, pp. 378-387

  2. Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management

    Clinical Nutrition, Vol. 39, Núm. 4, pp. 1292-1300

2019

  1. Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol in humans. A randomized, controlled trial

    Free Radical Biology and Medicine, Vol. 143, pp. 471-481

  2. Data on the endogenous conversion of tyrosol into hydroxytyrosol in humans

    Data in Brief

  3. N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function

    Frontiers in Nutrition, Vol. 6

  4. Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Answer to the Letter to the Editor Concerning “Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism”

    Obesity Surgery

  2. Non-linear formation of EtG and FAEEs after controlled administration of low to moderate doses of ethanol

    Alcohol and Alcoholism, Vol. 52, Núm. 5, pp. 587-594

  3. Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism

    Obesity Surgery, Vol. 27, Núm. 12, pp. 3194-3201

2016

  1. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

    PLoS ONE, Vol. 11, Núm. 2

  2. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial

    The Lancet Neurology, Vol. 15, Núm. 8, pp. 801-810

  3. VNTR-DAT1 and COMTVal158Met genotypes modulate mental flexibility and adaptive behavior skills in down syndrome

    Frontiers in Behavioral Neuroscience, Vol. 10, Núm. OCT

2015

  1. A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials

    Frontiers in Psychology, Vol. 6, Núm. JUN

  2. Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake

    Psychopharmacology, Vol. 232, Núm. 11, pp. 1921-1929

  3. Ethanol induces hydroxytyrosol formation in humans

    Pharmacological Research, Vol. 95-96, pp. 27-33

  4. Semantic verbal fluency pattern, dementia rating scores and adaptive behavior correlate with plasma Aβ42concentrations in down syndrome young adults

    Frontiers in Behavioral Neuroscience, Vol. 9, Núm. NOVEMBER

2014

  1. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans

    Molecular Nutrition and Food Research, Vol. 58, Núm. 2, pp. 278-288